Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer

First-line treatment in HR+/HER2- ABC: Patient cases (ID 13)

Lecture Time
11:35 - 12:00
Session Name
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30
Speakers
  • Sherko Kuemmel (Essen, Germany)
Authors
  • Sherko Kuemmel (Essen, Germany)